According to a new study, the blood-thinning drug Apixaban puts patients at risk for no clear benefit. The drug has been used as a potential life-saver for those recovering from severe COVID-19. But the research suggests that it does not work and can cause major bleeding. Molly Gambhir brings you the details.

WION Fineprint: How effective is blood-thinning therapy for COVID patients?

According to a new study, the blood-thinning drug Apixaban puts patients at risk for no clear benefit. The drug has been used as a potential life-saver for those recovering from severe covid-19. But the research suggests that it does not work and can cause major bleeding.

blood-thinning

Blood Thinning, News on Blood Thinning, stories on Blood Thinning, articles on Blood Thinning, Blood Thinning stories at Wion, Blood Thinning news, Blood Thinning latest news

blood thinning

WION Fineprint: How effective is blood-thinning therapy for COVID patients?

WION Fineprint: How effective is blood-thinning therapy for COVID patients?